October Pharma S.A.E (EGX: OCPH)

Market Cap	1.30B
Revenue (ttm)	1.19B
Net Income (ttm)	184.44M
Shares Out	12.00M
EPS (ttm)	8.93
PE Ratio	12.12
Forward PE	n/a
Dividend	2.50 (2.31%)
Ex-Dividend Date	May 28, 2024

Volume	144
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	80.00 - 166.99
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2024

About October Pharma S.A.E

October Pharma S.A.E manufactures and sells pharmaceutical products in Egypt. The company provides its products in solid forms, such as tablets, capsules, and powders; liquid forms comprising syrups, drops, solutions, and sprays; creams and suppositories; soft gelatin capsules; and ampoules and vials. October Pharma S.A.E was founded in 1987 is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: OCPH

Financial Performance

In 2023, October Pharma S.A.E's revenue was 1.01 billion, an increase of 39.08% compared to the previous year's 727.37 million. Earnings were 150.40 million, an increase of 32.24%.